Skip to main content
Clinical Trials/NCT05486273
NCT05486273Not yet recruitingNot Applicable

Evaluation of the Impact of Sports-inspired Onco-coaching on Health-related Quality's Life of the Patients in Cancer Remission After Allogeneic Transplantation of Hematopoietic Stem Cells : a Randomized Controlled Trial REBOND2-IPC 2022-009

Institut Paoli-Calmettes0 sites108 target enrollmentStarted: January 2, 2023Last updated:
Conditions
Interventions

Trial Snapshot

Phase
Not Applicable
Status
Not yet recruiting
Sponsor
Enrollment
108
Primary Endpoint
To measure the impact of a coaching program on the patient's health-related quality of life 15 months post-transplant (M15/R12).

Study Overview

Brief Summary

To measure the impact of a coaching program on the patient's health-related quality of life 15 months post-transplant (M15/R12).

Detailed Description

After signing the consent form and validating the inclusion and non-inclusion criteria, patients will be included in the study. They will be randomized unequally (2:1) into one of the study groups:

  • OC (Onco-Coaching) group: patients will undergo onco-coaching sessions at a rate of 1 session/month until 6 months post-inclusion (M9/R6). 73 patients will be randomized in this group
  • Group C (Control): Patients will not receive onco-coaching follow-up, but will be able to benefit from classical management in full autonomy. 35 patients will be randomized in this group

Study Design

Study Type
Interventional
Allocation
Randomized
Intervention Model
Parallel
Primary Purpose
Other
Masking
None

Eligibility Criteria

Ages
18 Years to — (Adult, Older Adult)
Sex
All
Accepts Healthy Volunteers
No

Inclusion Criteria

  • •Be at least 18 years of age and have a good understanding and practice of the French language,
  • •Have been treated by an allogeneic hematopoietic stem cell transplant
  • •Signed consent to participate,
  • •Affiliation with a social security plan, or beneficiary of such a plan.

Exclusion Criteria

  • •Patients under treatment for complications (infections, GvHD,...) except patients with cGvHD requiring corticosteroid therapy less than or equal to 1 mg/kg daily
  • •Patient with progressive or relapsing hematological disease,
  • •Person in an emergency situation, adult under legal protection (guardianship, curatorship or safeguard of justice), or unable to express his/her consent,
  • •Person requiring psychotherapeutic care
  • •Impossibility to submit to the follow-up of the trial for geographical, social or psychological reasons.

Arms & Interventions

Groupe OC (Onco-Coaching)

Experimental

You will be offered 6 coaching sessions at a rate of one session per month. The first session will take place in the month following your inclusion in the study.

The study also includes the evaluation, by quality of life questionnaires, of the well-being variables (Self-efficacy, Capabilities, PANAS and Life Satisfaction, Hope, Anxiety and Depression in hospital, Subjective well-being and Health benefit).

They should be completed at the time of inclusion in the protocol at 1, 3, 6, 9 and 12 months after inclusion. The purpose of these interviews is to ask more specific questions about the impact of the program.

Intervention: interviews with coachs, semi-structured interviews and questionnaires (Other)

Groupe C (Contrôle)

Active Comparator

the patient will have standard management including also questionnaires and semi-structured interviews within the same time frame as the experimental arm.

Intervention: semi-structured interviews and questionnaires (Other)

Outcomes

Primary Outcomes

To measure the impact of a coaching program on the patient's health-related quality of life 15 months post-transplant (M15/R12).

Time Frame: from inclusion(RO=M3) to R12( Month 15 =12 month post inclusion)

evolution over time of the FACT-BMT( Functional Assessment of Cancer Therapy - Bone Marrow Transplantation) score during the first 15 months after transplantation the highest score corresponds to a worse condition of the patient.the value are between 0 and 200

Secondary Outcomes

  • To measure the impact of a coaching program on patient quality of life sub-dimensions 15 months post-transplant (M15/R12).(from inclusion(RO=M3) to R12(Month15 =12 month post inclusion))
  • Evaluate the cost-utility of the coaching program.(from inclusion(RO=M3) to R12(Month15 =12 month post inclusion))
  • Measure the impact of a coaching program on the patient's empowerment (capabilities, subjective well-being, hope and self-efficacy).(from inclusion(RO=M3) to R12(Month15 =12 month post inclusion))
  • Assess correlations between quality of life and patient empowerment(from inclusion(RO=M3) to R12(Month15 =12 month post inclusion))
  • Assess the overall survival of participants(from inclusion(RO=M3) to R12(Month15 =12 month post inclusion))
  • Measure the impact of a coaching program on reducing emotional distress.(from inclusion(RO=M3) to R12(Month 15 =12 month post inclusion))

Investigators

Sponsor
Institut Paoli-Calmettes
Sponsor Class
Other
Responsible Party
Sponsor

Similar Trials